- $50.7 million of series 2015A revenue refunding bonds
- $87 million of series 2007A revenue refunding bonds
The outlook is revised to negative from stable. The revision is based on several factors, including MBHS’ continued operating losses and decline in liquidity.
More articles on healthcare finance:
CoxHealth picks LUMEDX to unify cardiology data
To fear consolidation, or not to fear? How industry mega-payers may affect provider reimbursements
South Dakota hospital to lose Medicare funding
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
